Anlotinib Monotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter Case-Series Analysis: Anlotinib in NPC. Radiol Oncol. 2025;59(4):617-623. Accessed September 21, 2026. https://www.radioloncol.com/index.php/ro/article/view/4451